Omid Motabar

Title: The Innovative Mind of Omid Motabar

Introduction

Omid Motabar, based in Darnestown, MD, has made significant contributions to the field of pharmaceuticals with his innovative research and inventions. He is recognized for his expertise in developing compounds that target lysosomal storage disorders, particularly Gaucher disease. With three patents to his name, Motabar continues to push the boundaries of scientific discovery.

Latest Patents

Omid Motabar's latest patents focus on "Substituted pyrazolopyrimidines as glucocerebrosidase activators." These patents describe substituted pyrazolopyrimidines and dihydropyrazolopyrimidines, along with their methods of manufacture, compositions containing these compounds, and their application in treating lysosomal storage disorders like Gaucher disease. The compounds are characterized by a general Formula (I) where the variables R, R, and X are detailed within the application.

Career Highlights

Motabar's work is notably associated with the Government of the United States of America, particularly through the Department of Health and Human Services. His research not only contributes to scientific advancement but also aids in the development of therapeutic options for patients with genetic disorders.

Collaborations

Throughout his career, Omid Motabar has collaborated with esteemed coworkers such as Juan Jose Marugan and Noel Terrence Southall. These partnerships enhance the research environment and promote innovative solutions in the field of healthcare and pharmaceuticals.

Conclusion

Omid Motabar exemplifies the spirit of innovation within the scientific community. With his impactful patents and collaborative efforts, he is making strides in the treatment of lysosomal storage disorders. His contributions are not only significant in the realm of science but also pave the way for future advancements in medical therapy.